Nanobubble scientists convene at NJIT to share environmental research
Meeting Announcement
The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a conference to explore the latest research on cancer therapeutics, highlighting advances in the development of next-generation treatment modalities and the technologies enabling them. “Next Generation Cancer Therapeutics” is scheduled for Oct. 6-8, 2026, on the UT MD Anderson campus.
Following the publication of its latest study in Nature Biotechnology, Insilico Medicine founder and CEO Alex Zhavoronkov, Ph.D., took the stage at Sorbonne University during the Nature AI Conference on Redefining Healthcare in the Age of AI to deliver a detailed presentation of the breakthrough findings.
Addressing an audience of global research leaders, clinical investigators, and biopharma innovators, Zhavoronkov detailed how the company’s AI-driven novel drug candidate, rentosertib (ISM001-055), achieved a unanimous reversal of biological age across six independent proteomic aging clocks in a Phase IIa clinical trial.
In the late 1800s, newspapers ran alarming headlines about a dangerous new technology corrupting the nation’s youth. Books. Kids were sneaking off to libraries to read Horatio Alger, and parents were convinced it would ruin them. More than a century later, the medium has changed dramatically. But the fear, experts say, has not. The tension between panic and practicality was at the heart of a packed panel discussion Sept. 8 at UC Irvine, the third installment of the “Raising the Next Generation in the Age of AI” series. Co-presented by UCI’s School of Social Ecology, the Donald Bren School of Information and Computer Sciences, the Office of Research, the Connected Learning Lab, and CERES (Connecting the EdTech Research EcoSystem), the event brought together researchers, a tech industry leader and a youth advocate for a candid, research-grounded conversation about helping families navigate the challenges of raising children in an increasingly digital world.
September 14-16 | New York, USA
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the Morgan Stanley 24th Annual Global Healthcare Conference in New York from September 14 to 16.
September 14-16 | Riyadh, Saudi Arabia
Dr. Alex Aliper, Co-Founder and President of Insilico Medicine, has been invited to attend the Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 from September 14 to 16.
September 17-19 | Shanghai, China
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the Bio-Shanghai Week 2026. On September 17 at 3:00 PM.
September 18 | Boston, USA
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the Harvard IvyTech Discussion on September 18.
As scientific debate intensifies over solar geoengineering, clean energy constraints, and political influence on research, Frontiers Science House convenes leading scientists, business leaders, and policy heads during Climate Week NYC. Journalists can attend in person or online and request one-on-one speaker interviews.
On July 8, Korea University College of Medicine held the 1st Yale-Korea University Urology Symposium at Yukwangsa Hall on the second floor of the College of Medicine's main building.
A global forum was held to discuss the future of “Physical AI,” a technology that enables artificial intelligence to perceive, understand, and act in the real world through the physical embodiment of robots and machines. Experts from industry, academia, and research institutions in Korea and abroad gathered to share the latest technological developments in humanoid robotics and Physical AI and explore future directions for the industrial ecosystem.
The Korea Institute of Machinery and Materials (KIMM, President Seog-Hyeon Ryu) hosted the 2026 Global Forum on Mechanical Engineering beginning at 1:30 p.m. on September 7 (Monday) at the Science and Technology Convention Center in Seoul under the theme “Robotics Shaping Tomorrow's Industrial Ecosystem with Physical AI.”